Key result
During a 2014 surveillance in France, EV-D68 was detected in 5% of respiratory samples from hospitalized children and 1.1% from adults, with asthma and bronchiolitis as the main symptoms.
Cross-Sectional (n=6,229)
Yes
Answers are grounded in this paper and cite their sources.
The 2014 EV-D68 outbreak in France primarily affected children, presenting mainly as asthma or bronchiolitis, with a notable proportion requiring intensive care.
In 2014, the United States (US) experienced a nationwide outbreak of enterovirus D68 (EV-D68) infection with 1,152 cases reported mainly in hospitalised children with severe asthma or bronchiolitis. Following the US alert, 11 laboratories of the French enterovirus (EV) surveillance network participated in an EV-D68 survey. A total of 6,229 respiratory samples, collected from 1 July to 31 December 2014, were screened for EV-D68 resulting in 212 EV-D68-positive samples. These 212 samples corresponded to 200 EV-D68 cases. The overall EV-D68 positivity rates among respiratory samples were of 5% (184/3,645) and 1.1% (28/2,584) in hospitalised children and adults respectively. The maximum weekly EV-D68 positivity rates were of 16.1% for children (n = 24/149; week 43) and 2.6% for adults (n = 3/115; week 42). Of 173 children with EV-D68 infection alone, the main symptoms were asthma (n = 83; 48.0%) and bronchiolitis (n = 37; 21.4%). One child developed acute flaccid paralysis (AFP) following EV-D68-associated pneumonia. Although there was no significant increase in severe respiratory tract infections reported to the French public health authorities, 10.7% (19/177) of the EV-D68 infected children and 14.3% (3/21) of the EV-D68 infected adults were hospitalised in intensive care units. Phylogenetic analysis of the viral protein 1 (VP1) sequences of 179 EV-D68 cases, revealed that 117 sequences (65.4%), including that of the case of AFP, belonged to the B2 variant of clade B viruses. Continuous surveillance of EV-D68 infections is warranted and could benefit from existing influenza-like illness and EV surveillance networks.
No takes yet. Share an insight, caveat, or question.
Schuffenecker et al. (2016) conducted a cross-sectional in Enterovirus D68 infection (n=6,229). Enterovirus D68 infection was evaluated on EV-D68 positivity rate. During a 2014 surveillance in France, EV-D68 was detected in 5% of respiratory samples from hospitalized children and 1.1% from adults, with asthma and bronchiolitis as the main symptoms.
Synapse has enriched 10 related papers. Consider them for comparative context: